Abstract
The purpose of this study was the evaluation of the effectiveness of intrapericardial administration of tetracycline, 5-fluorouracil and cisplatin in patients with recurrent malignant pericardial effusion. In 33 cases with malignant pericardial effusion 46 pericardiocenteses under two-dimensional echo-cardiography were performed. No complications were observed after this procedure. Pericardiocentesis was followed by catheterization of the pericardial space for a mean period of 15 days (range 1–64). In 4 cases bacterial pericarditis was observed during catheterization. The mean volume of the pericardial fluid was 2.4 l (range 0.4–13 l). In cases with bloody pericardial fluid thePO2,PCO2 and pH of the fluid were estimated and the results compared with the values for venous blood obtained from the upper limbs. Highly statistically significant differences were documented. Twenty cases of malignant pericardial effusion were treated with direct pericardial administration of cisplatin, 3 with 5-fluorouracil and 2 with tetracycline. Good results (no fluid reaccumulation) were observed only after cisplatin therapy. We conclude that pericardiocentesis performed under two-dimensional echo cardiography, followed by pericardial catheterization and direct pericardial treatment with cisplatin are the methods of choice in cases with malignant pericardial effusion. In cases with bloody pericardial fluidPO2,PCO2 and pH analysis can be useful to differentiate the source of the bloody fluid (blood or bloody fluid).
Article PDF
Avoid common mistakes on your manuscript.
References
Celermajer DS, Boyer MJ, Bailey BP, et al (1991) Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients. Med J Aust 154:19–22
Davis S, Sharma SM, Blumberg ED, et al (1978) Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion. N Engl J Med 299:1113–1114
Fiorentino MV, Daniele O, Morandi P, et al (1988) Intrapericardial instillation of platin in malignant pericardial effusion. Cancer 62:1904–1906
Gaast A van der, Kok TC, Linden N van der, et al (1989) Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. Eur J Cancer Clin Oncol 25:1505–1506
Kralstein J, Frishman W (1987) Malignant pericardial diseases: diagnosis and treatment. Am Heart J 113:785–790
Markman M, Howell SB (1985) Intrapericardial instillation of cisplatin in a patient with a large malignant effusion. Cancer Drud Deliv 2:49–52
Okamoto H, Shinkai T, Yamakido M, et al (1993) Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer 71:93–98
Tomkowski W, Szturmowics M, Fijałkowska A, et al (1991) Intrapericardial cisplatin in malignant pericardial effusion. Eur J Cancer 27 [Suppl 3]:57
Tomkowski W, Szturmowicz M, Fijalkowska A, et al (1993) Intrapericardial cisplatin in patients with malignant pericardial effusion. Eur J Cancer 29 [Suppl 6]:110
Tomkowski W, Szturmowicz M, Fijałkowska A, et al (1994) Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. J Cancer Res Clin Oncol 120:434–436
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tomkowski, W., Szturmowicz, M., Fijałkowska, A. et al. New approaches to the management and treatment of malignant pericardial effusion. Support Care Cancer 5, 64–66 (1997). https://doi.org/10.1007/BF01681964
Issue Date:
DOI: https://doi.org/10.1007/BF01681964